Oral carcinogenesis is a multifactorial process involving numerous genetic events that alter normal functions of oncogenes and tumour suppressor genes.
This may increase the production of growth factors or the number of receptors on the cell surface, and/or increase transcription factors or intracellular signal messengers.
Together with the loss of tumour suppressor activity, these changes lead to a cell phenotype that can increase cell proliferation, with loss of cell cohesion, and infiltration of adjacent tissue thus causing distant metastasis. Molecular pathology is responsible for defining the molecular mechanisms that underlie the onset of oral precancer and cancer.
The aim of this review is to describe recent advances in our understanding of the molecular control of the innumerable pathways related to these processes. These may lead to short- or medium term improvements in the diagnosis and prognosis of oral precancerous and cancerous lesions and to the development of novel therapeutic approaches to this disease.
Authors: J. CAMPO-TRAPERO, J. CANO-SÁNCHEZ, B. PALACIOS-SÁNCHEZ, JJ. SÁNCHEZ-GUTIERREZ, M.A. GONZÁLEZ-MOLES and A. BASCONES-MARTÍNEZ
Source: https://ar.iiarjournals.org/
Products 27 March 2026
Garrison Dental Solutions has announced important enhancements to its Quad Matrix System with the release of updated Quad Wedges, building on the system’s strong clinical adoption for complex Class...
Products 20 February 2026
DEXIS™, a global leader in dental imaging, today introduced its most advanced update yet to the DTX Studio™ platform—bringing AI-driven diagnostics and multi-site connectivity designed to...
Periodontology 10 September 2025
To update the findings of a systematic review from the year 2016 on the evidence for the accuracy and potential benefits of cone beam computed tomography (CBCT) in periodontal diagnostics.
New surgical kits, a 6.0-mm implant, and upgraded accessories elevate the clinical ease and versatility of the company’s flagship system.
News 31 January 2025
Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025.
You may have noticed that more and more of your patients have started seeking toothpastes that are free of Sodium Lauryl Sulfate (SLS).
News 22 April 2026
Multi-segment series highlights how oral health connects to overall health and why connected care matters
News 22 April 2026
The New York State Dental Association (NYSDA) today called on state lawmakers to reject proposed reductions to the pass-through entity tax (PTET) credit
Graduating students presented research spanning artificial intelligence, clinical care, and global health
Implantology 22 April 2026
To update in new biopolymers and innovations for ocular prostheses and visual implants for visual care.